IRIS publication 235378895
The gut microbiota-a clinical perspective on lessons learned
RIS format for Endnote and similar
TY - JOUR - Shanahan, F. - 2012 - October - Nature Reviews Gastroenterology ; Hepatology - The gut microbiota-a clinical perspective on lessons learned - Validated - () - 9 - 1010 - 609 - 614609 - Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management. - 1759-50451759-5045 - ://WOS:000309592200008://WOS:000309592200008 DA - 2012/10 ER -
BIBTeX format for JabRef and similar
@article{V235378895, = {Shanahan, F. }, = {2012}, = {October}, = {Nature Reviews Gastroenterology ; Hepatology}, = {The gut microbiota-a clinical perspective on lessons learned}, = {Validated}, = {()}, = {9}, = {1010}, pages = {609--614609}, = {{Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.}}, issn = {1759-50451759-5045}, = {://WOS:000309592200008://WOS:000309592200008}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Shanahan, F. | ||
YEAR | 2012 | ||
MONTH | October | ||
JOURNAL_CODE | Nature Reviews Gastroenterology ; Hepatology | ||
TITLE | The gut microbiota-a clinical perspective on lessons learned | ||
STATUS | Validated | ||
TIMES_CITED | () | ||
SEARCH_KEYWORD | |||
VOLUME | 9 | ||
ISSUE | 1010 | ||
START_PAGE | 609 | ||
END_PAGE | 614609 | ||
ABSTRACT | Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management.Once considered obscure and largely ignored by microbiologists, the human microbiota has moved centre-stage in biology. The gut microbiota is now a focus of disparate research disciplines, with its contributions to health and disease ready for translation to clinical medicine. The changing composition of the microbiota is linked with changes in human behaviour and the rising prevalence of immunoallergic and metabolic disorders. The microbiota is both a target for drug therapy and a repository for drug discovery. Its secrets promise the realization of personalized medicine and nutrition, and will change and improve conventional dietary management. | ||
PUBLISHER_LOCATION | |||
ISBN_ISSN | 1759-50451759-5045 | ||
EDITION | |||
URL | ://WOS:000309592200008://WOS:000309592200008 | ||
DOI_LINK | |||
FUNDING_BODY | |||
GRANT_DETAILS |